Buerger's Disease Market 規模およびシェア分析 - 成長トレンドおよび予測 (2024 - 2031)

Buergers Disease Market is segmented By Treatment (Medications (Vasodilators, Anticoagulants, Calcium Channel Blockers, Antiplatelet Agents) Surgical Interventions (Sympathectomy, Amputation) , Advanced Therapies (Stem Cell Therapy, Gene Therapy, Hyperbaric Oxygen Therapy)), By Route of Administration (Oral, Injectable, Topical), By End User (Hospitals, Clinics, Specialty Centers, Research Institutes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned.

Competitive overview of Buerger's Disease Market

The major players operating in the Buerger's Disease Market include AnGes Inc., Mitsubishi Tanabe Pharma Corporation, Pluristem Therapeutics Inc., Stempeutics Research Pvt. Ltd., Fuji Yakuhin Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., and MediciNova, Inc.

Buerger's Disease Market Leaders

  • AnGes Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Pluristem Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd.
  • Fuji Yakuhin Co., Ltd.
*Disclaimer: Major players are listed in no particular order.

Buerger's Disease Market - Competitive Rivalry, 2023

Market Concentration Graph

Buerger's Disease Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights